Pet Health News Is Elanco Animal Health Elan The Best Pet Stock To Invest In According To Analysts

Elanco Animal Health (ELAN) Upgraded to Buy: What Does It Mean for the Stock?

Elanco Animal Health Incorporated (ELAN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in ... Read More

Elanco (NYSE:ELAN) Surprises With Q3 Sales

Animal health company Elanco (NYSE:ELAN) reported Q3 CY2025 results , with sales up 10.4% year on year to $1.14 billion. Guidance for next quarter’s revenue was better than expected at $1.10 billion ... Read More

Hsbc Holdings PLC Has $248,000 Stake in Elanco Animal Health Incorporated $ELAN

Hsbc Holdings PLC decreased its stake in shares of Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) by 78.8% in the 1st quarter, according to the company in its most recent filing with the ... Read More

Compared to Estimates, Elanco Animal Health (ELAN) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, Elanco Animal Health Incorporated (ELAN) reported revenue of $1.14 billion, up 10.4% over the same period last year. EPS came in at $0.19, compared to $0.13 in ... Read More

UBS Maintains Elanco Animal Health (ELAN) Buy Recommendation

Fintel reports that on October 20, 2025, UBS maintained coverage of Elanco Animal Health (NYSE:ELAN) with a Buy recommendation. As of September 30, 2025, the average one-year price target for Elanco ... Read More

ELAN COURT ALERT: ELANCO ANIMAL HEALTH (ELAN) Investors that Suffered Losses are Alerted of a Pending Class Action - Contact BFA Law before December 6 Court Deadline

NEW YORK, NY / ACCESSWIRE / November 15, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and ... Read More

Elanco gets FDA nod to remove vaccine risk warning from Zenrelia label

Elanco Animal Health (NYSE:ELAN) on Tuesday reported key updates to the U.S. label for Zenrelia, after the FDA reviewed additional scientific data, sending shares up 1.1% in premarket trading. The ... Read More

Elanco upgraded at J.P. Morgan on product launch cycle

J.P. Morgan upgraded Elanco Animal Health (NYSE:ELAN) to Overweight from Neutral on Tuesday, arguing that the veterinary product maker is set to accelerate its revenue growth over the next few years ... Read More

Peering Into Elanco Animal Health Inc's Recent Short Interest

According to Benzinga Pro, Elanco Animal Health Inc's peer group average for short interest as a percentage of float is 3.43%, which means the company has more short interest than most of its peers. Read More

Elanco reports pet parasite treatment quickly hit $100M blockbuster status

Greenfield-based Elanco Animal Health announced Monday that its medicine targeting six common pet parasites reached $100 million in sales in just eight months, the company’s fastest pet-health ... Read More